Moreover, high numbers of CD8+ T cells are positively correlated with the patients’ low lymph node metastasis rates, tumor recurrence rates, and longer survival times in various human cancers, such as melanoma (5), ovarian carcinoma (6), and head/neck squamous cell carcinoma (HNSCC) (7). This evidence concerns the gene CD8A and neoplasm.